Bringing our partners next generation cell and gene therapy manufacturing solutions.

Coming April of 2018, we will launch cGMP production of

a bead-free QuickGel platform for enhanced cell therapy manufacturing

Giving our partners the advantages of reducing unit operations, more desirable phenotypes, greater transduction efficiencies, and overall manufacturing scalability.